Estrella Immunopharma, Inc. is an early-stage biopharmaceutical enterprise focused on creating T-cell therapies for various blood cancers and solid tumors, with its primary activities centered in the United States.
Estrella Immunopharma stock last closed at $0.64, down 0.31% from the previous day, and has decreased 38.06% in one year. It has underperformed other stocks in the Biotechnology industry by 0.28 percentage points. Estrella Immunopharma stock is currently +9.06% from its 52-week low of $0.59, and -79.75% from its 52-week high of $3.15.
As of Sep 9, 2026, there are 43.5M shares of ESLA outstanding. The market capitalization of ESLA is $27.75M. In the past 24 hours, 28,600 ESLA shares were traded.
You will need an online brokerage account to access the NASDAQ market and buy ESLA shares.
We believe that eToro is the best brokerage. eToro gives you:
Get $10 towards your purchase of shares by signing up for an account with eToro now. This offer is only for US users.
Open eToro AccountNow that you've chosen the best brokerage, you need to fill out some personal details so you are able to invest in ESLA today.
Now that you've finished signing up on a mobile trading app, you need to deposit funds:
Check out the video below for more details transferring money into your investment account.
Once you have decided on the best place to buy Estrella Immunopharma stock, it's important to evaluate their stock before you invest, so you can understand the risk and upside.
WallStreetZen was designed to help everyday investors perform better fundamental analysis quickly.
You can see all of the due diligence checks on ESLA's stock page.
Investors use a variety of different financial metrics, analyses, models, and charts to gauge ESLA's true value.
You can do additional valuation research on ESLA's stock here.
You can dive deeper into what analysts are projecting on the Estrella Immunopharma stock forecast page.
In the last 12 months, insiders at ESLA have bought more shares than they have sold.
Cheng Liu, CEO of ESLA, was the latest ESLA insider to buy. They bought $81,500.00 worth of ESLA stock on Aug 25, 2026.
Learn more about who owns ESLA shares here.
No, Estrella Immunopharma doesn't provide an income stream by paying out dividends.
One of the primary reasons eToro is our highest-rated brokerage is because of its social trading community.
Click below to find out what other community members have to say.
You have two main order types:
Press the Open button and eToro will place the order.
If you need additional help with investing in stocks on eToro, click the how to video below:
Now that you own some shares in ESLA, you'll want to keep up with your shares.
Put ESLA on a watchlist to see the latest developments about your ESLA stock.
To summarize, here are the 6 steps to buy stock in Estrella Immunopharma:
If you are looking for a online brokerage, eToro is our recommended venue.
Get Started with eToro TodayIf you want to keep track of your new investment in Estrella Immunopharma, add ESLA to your watchlist below.